Efficacy and tolerability of peginterferon alfa-2a or alfa-2b plus ribavirin in the daily routine treatment of patients with chronic hepatitis C in Germany: The PRACTICE Study

Erstveröffentlichung

2010

Authors

Witthöft, Thomas

Hueppe, D.

John, C.

Goelz, J.

Heyne, R.

et al.

Wissenschaftlicher Artikel

Published in

Journal of viral hepatitis ; 17 (2010), 7. - S. 459-468. - ISSN 1352-0504. - eISSN 1365-2893

Link to publication

https://dx.doi.org/10.1111/j.1365-2893.2009.01255.x

Institutions

UKU. Klinik für Innere Medizin I

Subject headings

[Free subject headings]: chronic hepatitis | HCV | PCR | pegylated interferon | ribavirin | sustained virological response | viral load | RANDOMIZED CONTROLLED-TRIAL | HIV-INFECTED PATIENTS | CHRONIC HCV INFECTION | VIRUS-INFECTION | COMBINATION THERAPY | NAIVE PATIENTS | MANAGEMENT | INTERFERON-ALPHA-2B | PHARMACOKINETICS
[DDC subject group]: DDC 610 / Medicine & health

Metadata

Show full item record